March 6, 2024
Company's innovative products and solutions improved the lives of 1.9 billion
people in 2023
Amsterdam, the Netherlands - Royal Philips (http://www.philips.com/newscenter)
(NYSE: PHG, AEX: PHIA), a global leader in health technology, has been included
in the 2024 Clarivate Top 100 Global Innovator(TM) list (https://clarivate.com/top-
100-
innovators/%20%20?campaignname=Top_100_Global_Innovators_Report_LeadGen_IP_Globa
l_2024%20&campaignid=7014N000001znaJQAQ&utm_campaign=Top_100_Global_Innovators_R
eport_LeadGen_IP_Global_2024%20&utm_source=Press_Release&utm_medium=Earned_Press
). Philips' global R&D programs and collaborations aim to deliver personal
health solutions for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home. Together with
healthcare providers and other ecosystem partners, Philips co-creates
innovations that increase access to healthcare globally and create sustainable
and resilient healthcare models.
For example, illustrating the global reach of its efforts to accelerate more
productive and sustainable MR imaging operations, Philips has installed more
than 1,000 MR systems (https://www.philips.com/a-
w/about/news/archive/standard/news/press/2024/philips-extends-leadership-in-
virtually-helium-free-mri-with-more-than-1000-systems-installed-expanding-
patient-access-worldwide.html) with its virtually helium-free BlueSeal magnet,
which requires only 0.5% of the helium of a conventional Philips MR system.
Additionally, Philips recently launched its new Azurion image-guided therapy
system (https://www.philips.com/a-
w/about/news/archive/standard/news/press/2024/philips-launches-new-azurion-
neuro-biplane-system-at-ecr2024-to-speed-up-and-improve-minimally-invasive-
diagnosis-and-treatment-of-neurovascular-patients.html) and advanced informatics
to enhance the minimally invasive diagnosis and treatment of neurovascular
patients and reduce the time clinicians require per patient.
Roy Jakobs, CEO of Royal Philips said: "At Philips, we've been innovating to
improve lives for over 130 years. People's needs are at the very heart of how we
innovate and design for sustainable impact with a 'safety and quality first'
mindset. Innovation is our core strength and will continue to be our core
differentiator. Recent industry trends have accelerated the adoption of
technology within healthcare. We are embracing these trends and shifting our
innovation to a more patient- and people-centric model closer to our customers."
Further examples of innovations that help clinicians increase productivity and
save time include Philips' recently introduced next-generation EPIQ Elite and
Affiniti ultrasound systems (https://www.philips.com/a-
w/about/news/archive/standard/news/press/2023/20231127-philips-improves-
workflow-and-efficiency-with-next-generation-ultrasound-systems-epiq-elite-and-
affiniti-at-rsna23.html) with AI and expanded tele-ultrasound capability, and
Philips' recently launched Philips HealthSuite Imaging
(https://www.philips.com/a-
w/about/news/archive/standard/news/press/2023/20231127-philips-launches-
healthsuite-imaging-a-cloud-based-next-generation-of-vue-pacs-with-new-ai-
enabled-clinical-and-operational-workflows-at-rsna23.html), a cloud-based
Picture Archiving and Communication System with high-speed remote access for
diagnostic reading and AI-enabled workflow orchestration.
The Top 100 Global Innovators uses a comparative analysis of global invention
data to assess the strength of every patented idea, using measures tied directly
to their innovative power. Philips has now been included in this reputable list
for eleven consecutive years and is the highest ranked company in the 'Medical
and biotechnology' industry in the 2024 report. The full report can be found
here (https://clarivate.com/top-100-
innovators/%20%20?campaignname=Top_100_Global_Innovators_Report_LeadGen_IP_Globa
l_2024%20&campaignid=7014N000001znaJQAQ&utm_campaign=Top_100_Global_Innovators_R
eport_LeadGen_IP_Global_2024%20&utm_source=Press_Release&utm_medium=Earned_Press
).
For further information, please contact:
Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com (mailto:ben.zwirs@philips.com)
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and well-being through meaningful
innovation. Philips' patient- and people-centric innovation leverages advanced
technology and deep clinical and consumer insights to deliver personal health
solutions for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-
guided therapy, monitoring, and enterprise informatics, as well as in personal
health. Philips generated 2023 sales of EUR 18.2 billion and employs
approximately 69,700 employees with sales and services in more than 100
countries. News about Philips can be found at www.philips.com/newscenter
(http://www.philips.com/newscenter).
Â